Literature DB >> 3954555

Outcome after 40 years in DSM-III schizophreniform disorder.

W Coryell, M T Tsuang.   

Abstract

In an earlier report, we described the course of the index episode and the family history of patients with schizophreniform disorder, schizophrenia, or affective disorder. Those data indicated that DSM-III schizophreniform disorder defined a heterogeneous group that bore a closer relationship to schizophrenia than to affective disorder. The present report extends the study of these same patients to a 40-year field follow-up. As the earlier short-term and family history findings predicted, marital, occupational, mental, and residential status ratings for the schizophreniform group assumed intermediate positions between those for patients with affective disorder and those for schizophrenics but fell closer to the latter. Contrary to the short-term outcome findings, the present data show no relationship between illness duration at index admission and outcome status ratings after 40 years.

Entities:  

Mesh:

Year:  1986        PMID: 3954555     DOI: 10.1001/archpsyc.1986.01800040030005

Source DB:  PubMed          Journal:  Arch Gen Psychiatry        ISSN: 0003-990X


  4 in total

1.  A follow-up and family study of DSM-III-R schizophreniform disorder with good prognostic features.

Authors:  F Benazzi; M Mazzoli; E Rossi
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  1992       Impact factor: 5.270

Review 2.  Outcome of schizophreniform disorder.

Authors:  Franco Benazzi
Journal:  Curr Psychiatry Rep       Date:  2003-07       Impact factor: 5.285

3.  A Preliminary Study of Rehabilitation Needs of In-patients and Out-patients with Schizophrenia.

Authors:  Sachin Gandotra; Sarita E Paul; Mercian Daniel; Krishan Kumar; Harsh A Raj; B Sujeetha
Journal:  Indian J Psychiatry       Date:  2004-07       Impact factor: 1.759

4.  Coaching for recovery: a quality improvement project in mental healthcare.

Authors:  Anna Burhouse; Madeleine Rowland; Heather Marie Niman; Daisy Abraham; Elizabeth Collins; Helen Matthews; Joanna Denney; Howard Ryland
Journal:  BMJ Qual Improv Rep       Date:  2015-11-11
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.